-The Information Report
Goldman Sachs Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $95
Goldman Sachs analyst Matthew Sykes initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $95.